Latest & greatest articles for tuberculosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on tuberculosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on tuberculosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for tuberculosis

61. Targeting Mycobacterium tuberculosis sensitivity to thiol stress at acidic pH kills the bacterium and potentiates antibiotics

Targeting Mycobacterium tuberculosis sensitivity to thiol stress at acidic pH kills the bacterium and potentiates antibiotics 28781126 2017 10 09 2018 11 13 2451-9448 24 8 2017 Aug 17 Cell chemical biology Cell Chem Biol Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics. 993-1004.e4 S2451-9456(17)30232-5 10.1016/j.chembiol.2017.06.018 Mycobacterium tuberculosis (Mtb) must sense and adapt to immune pressures (...) pharmacology Bacterial Proteins genetics metabolism Glutathione chemistry Hydrogen-Ion Concentration Mycobacterium tuberculosis drug effects growth & development Oxidative Stress drug effects Pyrimidines chemistry pharmacology Reactive Oxygen Species metabolism Sigma Factor genetics metabolism Structure-Activity Relationship Sulfhydryl Compounds chemistry metabolism Sulfones chemistry pharmacology Mycobacterium tuberculosis antibiotic potentiation chemical biology environmental adaptation oxidative stress

Cell chemical biology2017 Full Text: Link to full Text with Trip Pro

62. Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK

Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page (...) you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} BCG for tuberculosis in minority ethnic groups lasted at least 10 years and at least 20 years in white school-age children. {{author}} {{($index , , , , , , , , , , , & . Punam Mangtani 1, * , Patrick Nguipdop-Djomo 1 , Ruth H Keogh 1 , Lucy Trinder 1 , Peter G

NIHR HTA programme2017

63. Evaluating clinicians’ user experience and acceptability of LearnTB, a smartphone application for tuberculosis in India

Evaluating clinicians’ user experience and acceptability of LearnTB, a smartphone application for tuberculosis in India 28828377 2018 11 13 2306-9740 3 2017 mHealth Mhealth Evaluating clinicians' user experience and acceptability of LearnTB , a smartphone application for tuberculosis in India. 30 10.21037/mhealth.2017.07.01 Tuberculosis (TB) is the leading infectious killer, and India accounts for 2.8 of the 10.4 million TB cases that occur each year, making it the highest TB burden country (...) worldwide. Poor quality of TB care is a major driver of the epidemic in India. India's large private, unregulated sector manages over 50% of the TB patients, with studies showing suboptimal diagnosis and treatment in the private sector. Better education of doctors using mobile applications (apps) is a possible solution. While India has seen an explosion of mobile phone services, and while the use of mobile health interventions has been gaining interest, little is known about mHealth around tuberculosis

mHealth2017 Full Text: Link to full Text with Trip Pro

64. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis

Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis 28717643 2018 11 13 2312-0541 3 3 2017 Jul ERJ open research ERJ Open Res Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. 00026-2017 10.1183/23120541.00026-2017 Cross-sectional studies reveal an association between tuberculosis (TB) and chronic airflow obstruction, but cannot adequately address confounding. We hypothesised that treated pulmonary TB (...) vital capacity ratio <0.70 (adjusted OR 2.47, 95% CI 1.01-6.03). Individuals successfully treated for TB may experience long-lasting sequelae. Interventions facilitating earlier TB treatment and management of chronic respiratory disease should be explored. Byrne Anthony L AL Department of Medicine, Central Clinical School, University of Sydney, Sydney, Australia. Socios En Salud Sucursal Perú, Partners In Health, Lima, Peru. Centre for Research Excellence in Tuberculosis (TB-CRE), Sydney, Australia. Marais Ben J

ERJ open research2017 Full Text: Link to full Text with Trip Pro

65. Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis

Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis 29082351 2018 11 13 2468-2667 2 7 2017 Jul The Lancet. Public health Lancet Public Health Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis. e323-e330 10.1016/S2468-2667(17)30119-6 After steady decline since the 1990s, tuberculosis (TB) incidence in New York City (NYC) and the United States (US) has flattened. The reasons for this trend (...) of Medicine, 2024 Monument St., Baltimore, MD, USA 21205. Stennis Natalie L NL Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, 42-09 28th St, 21st floor, Long Island City, NY, USA 11101. Azman Andrew S AS Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St. Room E6531, Baltimore, MD, USA 21205. Kendall Emily A EA Division of Infectious Diseases, Johns Hopkins University School of Medicine, PCTB Suite 211, 725 N. Wolfe St

The Lancet. Public health2017 Full Text: Link to full Text with Trip Pro

66. An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients

An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients 28529202 2017 05 22 2017 06 11 1399-3003 49 5 2017 May The European respiratory journal Eur. Respir. J. An evaluation of automated chest radiography reading software for tuberculosis screening among public- and private-sector patients. 1602159 10.1183/13993003.02159-2016 Computer-aided reading (CAR) of medical images is becoming increasingly common, but few studies (...) exist for CAR in tuberculosis (TB). We designed a prospective study evaluating CAR for chest radiography (CXR) as a triage tool before Xpert MTB/RIF (Xpert).Consecutively enrolled adults in Dhaka, Bangladesh, with TB symptoms received CXR and Xpert. Each image was scored by CAR and graded by a radiologist. We compared CAR with the radiologist for sensitivity and specificity, area under the receiver operating characteristic curve (AUC), and calculated the potential Xpert tests saved.A total of 18 036

EvidenceUpdates2017 Full Text: Link to full Text with Trip Pro

67. Tuberculosis control, and the where and why of artificial intelligence

Tuberculosis control, and the where and why of artificial intelligence 28656130 2018 11 13 2312-0541 3 2 2017 Apr ERJ open research ERJ Open Res Tuberculosis control, and the where and why of artificial intelligence. 00056-2017 10.1183/23120541.00056-2017 Countries aiming to reduce their tuberculosis (TB) burden by 2035 to the levels envisaged by the World Health Organization End TB Strategy need to innovate, with approaches such as digital health (electronic and mobile health) in support

ERJ open research2017 Full Text: Link to full Text with Trip Pro

68. A novel clinical sign in intraocular tuberculosis: Active chorioretinitis within chorioretinal atrophy

A novel clinical sign in intraocular tuberculosis: Active chorioretinitis within chorioretinal atrophy 29152599 2018 11 13 2451-9936 7 2017 Sep American journal of ophthalmology case reports Am J Ophthalmol Case Rep A Novel clinical sign in Intraocular Tuberculosis: Active chorioretinitis within chorioretinal atrophy. 59-61 10.1016/j.ajoc.2017.06.001 To report a novel clinical sign in patients with intraocular tuberculosis. The current study is an observational consecutive case series (...) of patients diagnosed with intraocular tuberculosis managed at a tertiary eye care centre from June 1, 2012 to December 31, 2015. The diagnosis of intraocular tuberculosis was made in 6 patients based on ocular features suggestive of tuberculosis along with a positive tuberculin skin testing and chest X-ray consistent with tuberculosis. All patients presented with decreased visual acuity ranging from 20/25 to 20/400, anterior chamber reaction, vitritis, multifocal choroiditis and vasculitis. All patients

American journal of ophthalmology case reports2017 Full Text: Link to full Text with Trip Pro

69. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update 28331043 2017 03 23 2017 04 25 1399-3003 49 3 2017 Mar The European respiratory journal Eur. Respir. J. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. 1602308 10.1183/13993003.02308-2016 Antimicrobial resistance is a major global concern. Tuberculosis (TB) strains resistant to rifampicin and other TB medicines challenge patient survival and public health

EvidenceUpdates2017 Full Text: Link to full Text with Trip Pro

70. User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine

User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine 28512634 2018 11 13 2312-0541 3 2 2017 Apr ERJ open research ERJ Open Res User experience analysis of e-TB Manager, a nationwide electronic tuberculosis recording and reporting system in Ukraine. 00002-2017 10.1183/23120541.00002-2017 Ukraine has successfully implemented e-TB Manager nationwide as its mandatory national tuberculosis registry after first introducing it in 2009 (...) better user experience scores for at least six of the 12 measures compared to younger users (aged 18-29 years). Using the registry for >3 years was associated with significantly higher scores for having capacity, adequacy of training received and satisfaction with the registry. Of the 5.9 million transactions over a 4-year period, nine out of 24 oblasts (regions) and Kiev city accounted for 62.5% of all transactions, and corresponded to 59% of Ukraine's tuberculosis burden. There were 437 unique

ERJ open research2017 Full Text: Link to full Text with Trip Pro

71. FluoroType MTB system for the detection of pulmonary tuberculosis

FluoroType MTB system for the detection of pulmonary tuberculosis 28491868 2018 11 13 2312-0541 3 2 2017 Apr ERJ open research ERJ Open Res FluoroType MTB system for the detection of pulmonary tuberculosis. 00113-2016 10.1183/23120541.00113-2016 FluoroType MTB is a sensitive test for TB but specificity is low compared with fully integrated molecular systems http://ow.ly/WhEO30b1luY. Obasanya Joshua J Nigerian Centers for Disease Control, Abuja, Nigeria. Lawson Lovett L Zankli Research

ERJ open research2017 Full Text: Link to full Text with Trip Pro

72. Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked

Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked 29201785 2018 11 13 2231-5047 7 1 2017 Jan-Jun Euroasian journal of hepato-gastroenterology Euroasian J Hepatogastroenterol Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked. 97-98 10.5005/jp-journals-10018-1224 How to cite this article: Dayal S. Synchronous Colon Carcinoma and Tuberculosis: Coincidence or Linked. Euroasian J Hepato-Gastroenterol 2017;7(1):97-98. Dayal Seema S Department of Pathology, Uttar (...) Pradesh University of Medical Sciences, Etawah, Uttar Pradesh, India. eng Journal Article 2017 05 05 India Euroasian J Hepatogastroenterol 101577625 2231-5047 Carcinoma colon Intestinal tuberculosis Mycobacterium tuberculosis. Source of support: Nil Conflict of interest: None 2016 07 27 2016 09 04 2017 12 5 6 0 2017 12 5 6 0 2017 12 5 6 1 ppublish 29201785 10.5005/jp-journals-10018-1224 PMC5663787 Br J Dis Chest. 1975 Jul;69:207-10 1103928 N Engl J Med. 2002 Oct 31;347(18):1420-5 12409545 Gan

Euroasian journal of hepato-gastroenterology2017 Full Text: Link to full Text with Trip Pro

73. Do incentives and enablers improve adherence to tuberculosis treatment?

Do incentives and enablers improve adherence to tuberculosis treatment? Do incentives and enablers improve adherence to tuberculosis treatment? - NIPH Selected items added to basket Close Vis søkefelt How can we help you today? Search for: Søk Menu • • Do incentives and enablers improve adherence to tuberculosis treatment? Søk i Folkehelsa.no Search for: Søk Infectious diseases & Vaccines Close Mental & Physical health Close Environment & Lifestyle Close Health in Norway Close Quality

Norwegian Institute of Public Health2017

74. Renal Transplant–Associated Thyroid Tuberculosis

Renal Transplant–Associated Thyroid Tuberculosis 29264509 2018 11 13 2472-1972 1 5 2017 May 01 Journal of the Endocrine Society J Endocr Soc Renal Transplant-Associated Thyroid Tuberculosis. 553-559 10.1210/js.2016-1058 Tuberculosis is common among solid-organ transplant recipients, including renal transplants. Tuberculosis of the thyroid gland is a rare diagnosis. We report on a renal transplant recipient with subacute fever associated with a neck mass diagnosed as thyroid tuberculosis (...) . No prior publication has reported a case of posttransplant thyroid tuberculosis. This is an important diagnostic consideration, in addition to malignant transformation, in the posttransplant setting. Levitt David L DL Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland 21201. Mesmar Bayan B Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro

75. Delamanid (Deltyba) and multidrug-resistant pulmonary tuberculosis. For selected patients, with cardiac monitoring

Delamanid (Deltyba) and multidrug-resistant pulmonary tuberculosis. For selected patients, with cardiac monitoring Prescrire IN ENGLISH - Spotlight ''Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis. For selected patients, with cardiac monitoring'', 1 April 2017 {1} {1} {1} | | > > > Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis. For selected patients, with cardiac monitoring Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent (...) :  |   |   |   |   |   |   |   |   |  Spotlight Delamanid (Deltyba°) and multidrug-resistant pulmonary tuberculosis. For selected patients, with cardiac monitoring FEATURED REVIEW Despite delamanid's rather shaky evaluation, the available data suggest that this antibiotic should be offered to patients with multidrug-resistant tuberculosis. The noteworthy impact of delamanid on the QT interval warrants electrocardiographic

Prescrire2017

76. The mask of acute bacterial pneumonia may disguise the face of tuberculosis

The mask of acute bacterial pneumonia may disguise the face of tuberculosis 28461868 2018 11 13 2008-5842 9 3 2017 Mar Electronic physician Electron Physician The mask of acute bacterial pneumonia may disguise the face of tuberculosis. 3943-3949 10.19082/3943 Pulmonary tuberculosis (TB) can present as acute pneumonia. Differentiation of tuberculous from non-tuberculous community-acquired pneumonia (CAP) is an important challenge in endemic areas. The purpose of this study was the comparison (...) . Amiri Bezat B Infectious Diseases Resident, Department of Infectious Diseases and Tropical Medicine, Imam Reza Teaching Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. Nooghabi Mehdi Jabbari MJ Assistant Professor in Statistics, Department of Statistics, Ferdowsi University of Mashhad, Mashhad, Iran. eng Journal Article 2017 03 25 Iran Electron Physician 101645099 2008-5842 Community-Acquired Pneumonia Pneumonia Tuberculosis Conflict of Interest: There is no conflict of interest

Electronic physician2017 Full Text: Link to full Text with Trip Pro

77. India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality

India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality 28589035 2018 11 13 2059-7908 2 2 2016 BMJ global health BMJ Glob Health India's plan to eliminate tuberculosis by 2025: converting rhetoric into reality. e000326 10.1136/bmjgh-2017-000326 Pai Madhukar M McGill Global Health Programs & McGill International TB Centre, McGill University, Montreal, Canada. Manipal McGill Centre for Infectious Diseases, Manipal University, Manipal, India. Bhaumik Soumyadeep S BMJ

BMJ global health2017 Full Text: Link to full Text with Trip Pro

78. The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition

The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition 27780773 2017 05 03 2018 11 13 1769-714X 19 3 2017 Mar Microbes and infection Microbes Infect. The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. 177-192 S1286-4579(16)30146-0 10.1016/j.micinf.2016.10.001 Mycobacterium tuberculosis is a facultative anaerobe and its characteristic pathological hallmark (...) , the granuloma, exhibits hypoxia in humans and in most experimental models. Thus the host and bacillary adaptation to hypoxia is of central importance in understanding pathogenesis and thereby to derive new drug treatments and vaccines. Copyright © 2016 The Author(s). Published by Elsevier Masson SAS.. All rights reserved. Prosser Gareth G Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, 20892, United States

Microbes and infection2017 Full Text: Link to full Text with Trip Pro

79. Fumarase deficiency causes protein and metabolite succination and intoxicates Mycobacterium tuberculosis

Fumarase deficiency causes protein and metabolite succination and intoxicates Mycobacterium tuberculosis 28219662 2017 11 21 2018 11 13 2451-9448 24 3 2017 Mar 16 Cell chemical biology Cell Chem Biol Fumarase Deficiency Causes Protein and Metabolite Succination and Intoxicates Mycobacterium tuberculosis. 306-315 S2451-9456(17)30024-7 10.1016/j.chembiol.2017.01.005 Enzymes of central carbon metabolism are essential mediators of Mycobacterium tuberculosis (Mtb) physiology and pathogenicity (...) Citric Acid Cycle Cysteine chemistry Female Fumarate Hydratase deficiency genetics metabolism Fumarates analysis metabolism Mice Mice, Inbred C57BL Mycobacterium tuberculosis enzymology genetics pathogenicity Oxidative Stress Peptides analysis chemistry Protein Processing, Post-Translational Tandem Mass Spectrometry central carbon metabolism drug target fumarase succination tuberculosis 2016 09 11 2016 12 07 2017 01 19 2017 2 22 6 0 2017 11 29 6 0 2017 2 22 6 0 ppublish 28219662 S2451-9456(17)30024-7

Cell chemical biology2017 Full Text: Link to full Text with Trip Pro

80. Tuberculosis.

Tuberculosis. This issue provides a clinical overview of tuberculosis, focusing on screening, prevention, diagnosis, and treatment. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance

Annals of Internal Medicine2017